SoviHep (Sofosbuvir) Tweet
What is SoviHep (Sofosbuvir) used for?
Sovihep (Sofosbuvir) is prescribed as part of a combination therapy with pegylated interferon and/or ribavirin for the treatment of chronic hepatitis C in genotype 1, 2, 3 and 4. It can be used to treat patients awaiting liver transplantation and those with HCV/HIV-1 co-infection.
Sofosbuvir directly targets the hepatitis C virus to stop it from making copies of itself (replicating) in the liver and makes it harder for the virus to multiply.
How should I use SoviHep (Sofosbuvir)?
Sovihep (Sofosbuvir) will most commonly be prescribed at a starting dosage of 400mg (one tablet) per day. The tablet is taken orally, once daily with or without food. Sofosbuvir needs to be taken along with ribavirin or in combination with pegylated interferon and ribavirin for the treatment of chronic hepatitis C (CHC) in adults, depending on the genotype of hepatitis C present.
The recommended treatment plan for HCV patients as follows:
This information is general recommendation only. Your doctor or health care provider will provide you with further details.
What are the side effects of SoviHep (Sofosbuvir)?
The common side effects of taking Sovihep (Sofosbuvir) are:
If you notice any other side effects, or if the side effects listed above linger or become troublesome, you should contact your doctor.
Do not take this Sovihep (Sofosbuvir) alone. It is designed to be taken along with other drugs (pegylated interferon and ribavirin) to treat hepatitis C.
Taking Sovihep (Sofosbuvir) while pregnant can harm the fetus or cause serious birth defects. It is important to take a pregnancy test before starting treatment with Sovihep. If pregnancy occurs while either partner is taking sofosbuvir you must seek immediate medical attention.
If you are taking any other drugs or supplements, breast feeding, or decide to change dosage or stop taking Sovihep (Sofosbuvir), you should discussed with your doctor before hand.